Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
6.45
+0.30 (4.88%)
At close: May 12, 2025, 4:00 PM
6.48
+0.03 (0.47%)
After-hours: May 12, 2025, 7:35 PM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $487.32 million as of May 12, 2025. Its market cap has decreased by -18.30% in one year.
Market Cap
487.32M
Enterprise Value
296.91M
1-Year Change
-18.30%
Ranking
Category
Stock Price
$6.45
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $487.32M, a decrease of -18.15%. That is a compound annual growth rate of -3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 464.65M | -8.96% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |